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Abstract 
Sarah Puchala2, Joanne Lester1, Shana Straka1, Rachel Cole2, Martha A. Belury2, Lisa D. 
Yee1 1. Ohio State Medical Center Department of Surgery 2. Department of Human 
Nutrition 
 The metabolic syndrome (MetS) increases the risk of breast cancer in 
postmenopausal women.  Importantly, there are few reliable biomarkers for predicting 
risk for breast cancer. Because long-chain omega-3 fatty acids found in cold water fish 
may be protective against breast cancer and the MetS, we propose to evaluate the 
potential of erythrocyte levels of omega-3 fatty acids to serve as a blood biomarker for 
breast cancer risk.  The omega-3 index measures the percentage of the long-chained 
omega-3 fatty acids, eicosapentaenoic acid (EPA; 20:5n3) and docosahexaenoic acid 
(DHA; 22:6n3), to total erythrocyte fatty acids(1). The fatty acid composition of the 
erythrocytes was analyzed in relationship to obesity (BMI) and several other aspects of 
breast cancer risk in 25 women. In our cohort, the omega-3 index for women at-risk for 
breast cancer was 3.89% + 1.28 which is substantially lower compared with the 8% 
recommended omega-3 index by Harris for decreasing MetS risk. The omega-3 Index 
could be a useful biomarker for breast cancer, especially if used in conjunction with other 
risk factors, for predicting breast cancer risk in women. 1)  Harris WS, Am J Clin Nutr 
2008; 1999S.  Funding from the Fisheries Scholarship Fund and the Food Innovation 
Center (LDY). 
 
 
 
Introduction 
 There are currently no reliable blood biomarkers to assess breast cancer risk.  
There is the potential that long chain omega-3 fatty acids could be used as a biomarker to 
assess breast cancer risk.  Eicosapentanoic acid (EPA; 20:5n3) and Docosahexaenoic acid 
(DHA; 22:6n3) are omega-3 polyunsaturated fatty acids (PUFA). Fish oils are a rich 
source of omega-3 fatty acids.  Previous research has shown that diets supplemented with 
EPA and DHA suppressed tumor growth and metastasis of transplanted human mammary 
cancer in nude mice (1,2).  Consumption of EPA and DHA has shown reduction in the 
risk of coronary heart disease by lowering triglyceride levels and blood pressure (3), and 
potential anti-cancer effects (4).   
 Studies have shown that long-chain omega-3 fatty acids have anti-inflammatory 
effects and may suppress tumor growth in mouse models for breast cancer. Omega-6 fatty 
acids have the opposite effect in mice, having an inflammatory effect and stimulatory 
effect on tumor cell growth (1). The ratio of these omega-3 fatty acids to omega-6 fatty 
acids in the body may be important in mammary carcinogenesis.  Studies have shown an 
inverse relationship between this ratio and breast cancer (5).   
 Erythrocytes are a strong indicator of long-term omega-3 dietary intake. This is 
because omega-3 fatty acids are incorporated into the phospholipids of the cell 
membranes during both reticulocyte maturation and through plasma exchange making 
erythrocytes an accurate indicator of dietary fatty acid intake.  The Omega-3 Index is the 
sum of EPA+DHA in erythrocyte membranes as a percentage of total erythrocyte fatty 
acids.  When the omega-3 index was compared with other coronary heart disease risk 
factors such as cholesterol, triacylglycerols LDL, and HDL, C reactive proteins, and 
homocysteine only the omega-3 index and C reactive proteins had a statistically 
significant relation with risk for sudden cardiac death (6).  However, there have not been 
any studies looking at the omega-3 index and breast cancer risk.  The proposed cutoffs of 
<4% (low omega-3 index), 4-8% (intermediate omega-3 index), >8% (high omega-3 
index) were determined as cardioprotective target concentrations based on a review of the 
literature of what omega-3 index values were associated with the lowest risk for coronary 
heart disease (6).   
 Breast cancer screening and early detection are important because they can 
increase survival rates and decrease the seriousness of the treatment needed.  The Gail 
Model is used as a breast cancer risk assessment score. It takes into account a women’s 
age, age at first period, age at the time of birth of her first child, number of first degree 
relatives wtih breast cancer, number of past breast biopsies, number of breast biopsies 
showing atypical hyperplasia, and race (7).  The Gail Model was created based on 
analysis of Caucasian women in the Breast Cancer Detection Demonstration Project. It 
has been updated to assess the risk of African American, Asian, and Pacific Islander 
women.   It calculates both a 5 year and lifetime risk assessment score. A score greater 
than or equal to 1.66% is associated with an increased risk for breast cancer.  The tool 
measures absolute risk which determines the probability of developing breast cancer in a 
defined age interval. The Gail Model has been validated for Causian, Asaian, and Pacific 
Islanders but may underestimate the risk of African Americans.   
 
Methods 
 Packed erythrocyte fractions were obtained from whole blood samples and stored 
at -80°C.  These samples were obtained as baseline measurements from 25 women at 
high risk for breast cancer who were participating in a clinical trial with an omega-3 fatty 
acid intervention at the Stefanie Spielman Comprehensive Breast Center. Fatty acids 
were extracted and methylated from red blood cells using boron trifluoride and the 
samples were heated for 10 minutes at 100°C (8). Samples were centrifuged at room 
temperature at 3630 x g for 3 minutes and the hexane layer, which contains the lipid-
soluble components including fatty acid methyl was obtained, and inserted in a vial for 
analysis by gas chromatography. 
 Analysis of fatty acid methyl esters was completed by gas chromatography using 
a 30-m Omegawax™320 fused silica capillary column (Supelco, Bellefonte, PA). Oven 
temperature started at 175˚C and increased at a rate of 3˚ C/min until reaching 220˚C. 
Flow rate of the carrier gas helium was 30 mL/min. Retention times of samples were 
compared to standards for fatty acid methyl esters (Matreya, LLC, Pleasant Gap, PA, 
Supelco, Bellefonte, PA and Nu-Check Prep Inc, Elysian, MN). Fatty acids are reported 
as total identified fatty acids in erythrocyte samples (9). 
 
Results 
 All subjects had an Omega-3 index that was < 8%.  Fourteen subjects had an 
Omega-3 Index <4% and 9 subjects had an Omega-3 Index between 4-8%.  The average 
Omega-3 Index for our cohort of 25 women was 3.89% + 1.28%.  In this cohort of 
women with an omega-3 index less than 4% compared with those with an omega-3 index 
greater than 4%, there appeared to be no significant relationship with some predictors of 
the metabolic syndrome (Table 1: e.g., age, waist to hip ratio, and waist circumference or 
BMI.)   All of the subjects were classified as high risk for breast cancer (Table 2).  Risk 
factors for breast cancer included family history, high risk histology, personal history of 
breast cancer, and their Gail Score.  The average percentage of erythrocyte membrane 
fatty acids was calculated for the women with an omega-3 index < 4% and for the women 
with an omega-3 index between 4 and 8%.  There was a significant difference between 
their DHA, EPA, total omega-3 fatty acids, and total omega-6 fatty acids. There was not 
a significant difference between their total saturated fatty acid content or their total 
monounsaturated fatty acid content (Table 3). There was not a strong correlation between 
BMI and omega-3 index (Graph 1).  A higher Omega-3 Index correlated with a higher 
Gail Score for both the 5 year Gail Score and the Lifetime Gail Score (Graph 2 and 
Graph 3). 
Table 1: Demographics of the Subjects 
    Omega-3 index < 4%   
Overall 
Characteristic  (n = 25) 
Yes (n = 
16 ) No (n = 9) p value 
          
Age (y)1 
51.96 + 
13.74 
51.19+ 
9.05 
53.33+ 
20.24 0.717 
Body mass 
index1 
25.95 + 
4.31 
26.99 + 
4.09 
24.10 + 
4.29 0.109 
Waist to Hip 
Ratio1 0.82 + 0.06 .82 + .07 .82 + .05 1 
Waist (cm)1  
84.93 + 
11.63 
86.39 + 
11.60 
82.33 + 
11.91 0.414 
1. Mean + Standard Deviation 
 
Table 2. Classification of Breast Cancer Risk 
Risk Factor n subjects       
Family 
history 
20       
High risk 
histology 
4       
Personal hx 
breast CA 
1       
Gail score  Total scored >1.67 <1.67 Not 
applicable 
  20 17 3 5 
 
 
Table 3. Average Percentage of Erythrocyte Membrane Fatty Acids   
Omega-3 Index < 4%   
  Yes (n=16) No (n=9) p 
EPA1 0.51 +  0.23 0.40 + 0.12 0.72 + 0.25 <.001 
DHA1 3.37 + 1.09 2.76 + 0.45 4.48 + 1.02 <.001 
Omega-3 Index1 3.89 + 1.28 3.16 + .45 5.19 + 1.24 <.001 
Total Omega-3 Fatty Acids1 6.52 + 1.30 5.88 + 0.58 7.67 + 1.46 <.001 
Total Omega-6 Fatty Acids1 
35.35 + 
2.25 
36.03 + 
2.37 
34.13 + 
1.42 0.040 
Total Saturated Fatty Acids1 
44.57 + 
1.88 
44.53 + 
2.03 
44.64 + 
1.70 0.892 
Total Monounsaturated Fatty 
Acids1 
13.56 + 
0.88 
13.56 + 
0.78 
13.56 + 
1.09 1 
1, Mean + Standard Deviation         
  
 
 Discussion 
 Our overall hypothesis was that a higher omega-3 index would correlate with a 
lower risk for breast cancer.  However, we found that a higher Omega-3 Index correlated 
with a higher Gail Score for both the 5 year Gail Score and the Lifetime Gail Score. 
These findings are in opposition to our hypothesis.  This could be due to the small sample 
size of our study and the homogeneity of the subjects.  All the women were from central 
Ohio, classified as high risk for breast cancer, and were not allowed to be taking omega-3 
fish oil supplements for 120 days before the study.  In addition, there appears to be two 
outliers.  When this data is excluded, the correlation does not indicate that a higher 
Omega-3 Index correlated with a higher Gail Score for both the 5 year Gail Score and the 
Lifetime Gail Score.   
 All of the women were at a high risk for breast cancer and none of the women had 
an omega-3 index greater than 8%. This supports our hypothesis that those with a high 
risk for breast cancer will have a lower omega-3 index score.   
 
 
Limitations and Future Directions 
 Limitations in this study include the small, homogenous sample population.  A 
larger, broader population of subjects from throughout the country would be beneficial to 
analyze.  It would also be beneficial to look at women who have not already been 
classified as at high risk for breast cancer.  
 Future directions of the study should evaluate the dietary intake of fish oils using 
food frequency questionnaires to determine if foods are contributing to the 
polyunsaturated fatty acid profile, saturated fatty acid profile, and monounsaturated fatty 
acid profile.  Further analysis of data will evaluate the relationship of individual fatty 
acids, e.g., DHA and EPA, with Gail scores.    
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